NCT02219269

Brief Summary

The investigators will conduct a prospective observational cohort study to investigate factors that influence contraceptive method utilization among women with medical conditions. The investigators will also investigate how women with medical conditions access to contraception and family planning fellowship trained specialist. After the baseline questionnaire, there be a 3 month and 6 month follow up questionnaire to investigate continuation and satisfaction with the contraceptive method. This study is unique because it will allow us to explore doing collaborative family planning research at the multiple UC medical campuses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2014

Shorter than P25 for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 18, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

March 14, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

August 11, 2014

Last Update Submit

March 13, 2018

Conditions

Keywords

contraceptionfamily planningcomplex medical conditions

Outcome Measures

Primary Outcomes (1)

  • Contraceptive method continuation and satisfaction

    Questionnaire is used to report continued use and satisfaction with multiple choice answer: very satisfied, somewhat satisfied, dissatisfied. Questionnaires will be administered at 3 months and 6 months after recruitment.

    6 month

Secondary Outcomes (4)

  • History of unintended pregnancy

    6 months

  • Change in Medical Condition

    6 months

  • History of contraceptive methods used

    6 months

  • If Contraception is Accessed in post-partum or post-abortion setting

    6 months

Study Arms (1)

Medically complex contraception users

Cohort includes women of reproductive age with diverse medical conditions (listed in inclusion criteria) who are referred to Family Planning felowship-trained physicians, seeking contraception counseling and administration.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of women 18-45 years old and seeking contraception with the medical condition listed in inclusion criteria. Participants will be recruited from obstetrics and gynecology clinic at UCSD, UCLA, UCSF, UC Irvine and UC Davis. 250 participants will be enrolled. Approximately 50 cases will be recruited at each site.

You may qualify if:

  • Ethnic Background: No limitation, will include minorities
  • Sexually Active with men
  • Diagnosis with at least one of the following conditions
  • Diabetes and other endocrine disorders
  • Cardiovascular Disease, such as Ischemic Heart Disease, Valvular disease, hypertension or pulmonary hypertension
  • Epilepsy, Migraine, and other neurologic disorders
  • History of or current cancer
  • History of or planning Bariatric Surgery
  • History of or planning Solid Organ Transplant
  • Systematic Lupus Erythematous and other rheumatologic conditions
  • History of or current Venous Thrombosis Embolism
  • Other Medical Conditions (such as Sickle Cell Disease or Cystic Fibrosis)

You may not qualify if:

  • Pregnant at time of recruitment
  • History of hysterectomy, bilateral oophorectomy, or sterilization procedure
  • Unable to provide informed consent
  • Attempting to become pregnant at time of recruitment
  • Not sexually active with men
  • No active telephone number or email for follow up
  • Women who are pregnant will be excluded from this study. However, no pregnancy testing will be conducted; pregnancy status will be based on self-reporting by subjects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

UCLA

Los Angeles, California, 90095, United States

Location

UC Irvine

Orange, California, 92868, United States

Location

UC Davis

Sacramento, California, 95817, United States

Location

UCSD

San Diego, California, 92103, United States

Location

UCSF

San Francisco, California, 94117, United States

Location

Related Publications (2)

  • Center for Disease Control and Prevention. U.S Medical Eligibility Criteria for Contraceptive Use, 2010.MMWR 2010;59 (No.RR-4).76-81

    BACKGROUND
  • Mody SK, Cansino C, Rible R, Farala JP, Steinauer J, Harken T; University of California Family Planning Collaborative. Contraceptive use among women with medical conditions: Factors that influence method choice. Semin Perinatol. 2020 Aug;44(5):151310. doi: 10.1016/j.semperi.2020.151310. Epub 2020 Aug 20.

MeSH Terms

Conditions

Diabetes MellitusCardiovascular DiseasesEpilepsyMigraine DisordersNervous System DiseasesNeoplasmsLupus Erythematosus, SystemicThrombosis

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBrain DiseasesCentral Nervous System DiseasesHeadache Disorders, PrimaryHeadache DisordersConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesEmbolism and ThrombosisVascular Diseases

Study Officials

  • Jody Steinauer, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Radhika Rible, MD MS

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • Tabetha Harken, MD MPH

    UC Irvine

    PRINCIPAL INVESTIGATOR
  • Catherine Cansino, MD MPH

    UC Davis

    PRINCIPAL INVESTIGATOR
  • Sheila Mody, MD MPH

    UCSD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 11, 2014

First Posted

August 18, 2014

Study Start

June 1, 2014

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

March 14, 2018

Record last verified: 2018-03

Locations